Global Hemostats Market Insights, Forecast to 2026
Hemostats are agents used to compress or treat bleeding vessels in order to arrest hemorrhage. These products may reduce operating room time and decrease the number of blood transfusions required in surgical procedures. Hemostatic gents are available in various forms including pads, sponges, liquids, and powders.
For industry structure analysis, the Hemostats Industry is concentrate. The top five producers account for about 56.58% of the revenue market. Regionally, USA e is the biggest consumption area of Hemostats, also the leader in the whole Hemostats.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Hemostats 4900 market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Hemostats 4900 industry.
Based on our recent survey, we have several different scenarios about the Hemostats 4900 YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 2437.2 million in 2019. The market size of Hemostats 4900 will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Hemostats market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Hemostats market in terms of both revenue and volume.
Players, stakeholders, and other participants in the global Hemostats market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Production and Pricing Analyses
Readers are provided with deeper production analysis, import and export analysis, and pricing analysis for the global Hemostats market. As part of production analysis, the report offers accurate statistics and figures for production capacity, production volume by region, and global production and production by each type segment for the period 2015-2026.
In the pricing analysis section of the report, readers are provided with validated statistics and figures for price by manufacturer and price by region for the period 2015-2020 and price by each type segment for the period 2015-2026. The import and export analysis for the global Hemostats market has been provided based on region.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Hemostats market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of volume for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Hemostats market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Hemostats market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Hemostats market.
The following manufacturers are covered in this report:
For industry structure analysis, the Hemostats Industry is concentrate. The top five producers account for about 56.58% of the revenue market. Regionally, USA e is the biggest consumption area of Hemostats, also the leader in the whole Hemostats.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Hemostats 4900 market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Hemostats 4900 industry.
Based on our recent survey, we have several different scenarios about the Hemostats 4900 YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 2437.2 million in 2019. The market size of Hemostats 4900 will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Hemostats market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Hemostats market in terms of both revenue and volume.
Players, stakeholders, and other participants in the global Hemostats market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Production and Pricing Analyses
Readers are provided with deeper production analysis, import and export analysis, and pricing analysis for the global Hemostats market. As part of production analysis, the report offers accurate statistics and figures for production capacity, production volume by region, and global production and production by each type segment for the period 2015-2026.
In the pricing analysis section of the report, readers are provided with validated statistics and figures for price by manufacturer and price by region for the period 2015-2020 and price by each type segment for the period 2015-2026. The import and export analysis for the global Hemostats market has been provided based on region.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Hemostats market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of volume for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Hemostats market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Hemostats market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Hemostats market.
The following manufacturers are covered in this report:
- Ethicon
- Pfizer
- Baxter International Inc.
- C. R. Bard
- The Medicines Company
- Anika Therapeutics
- Advanced Medical Solutions
- Integra LifeSciences Corporation
- B Braun Melsungen AG
- Gelita Medical GmbH
- Equimedical
- Vascular Solutions
- Marine Polymer Technologies
- Z-Medica, LLC
- CryoLife
- BioCer Entwicklungs-GmbH.
- Biom'Up SAS
- Thrombin-Based Hemostats
- Oxidized Regenerated Cellulose Based Hemostats
- Combination Hemostats
- Gelatin Based Hemostats
- Collagen Based Hemostats
- Prehospital Treatment
- Hospital Treatment
1 STUDY COVERAGE
1.1 Hemostats Product Introduction
1.2 Key Market Segments in This Study
1.3 Key Manufacturers Covered: Ranking of Global Top Hemostats Manufacturers by Revenue in 2019
1.4 Market by Type
1.4.1 Global Hemostats Market Size Growth Rate by Type
1.4.2 Thrombin-Based Hemostats
1.4.3 Oxidized Regenerated Cellulose Based Hemostats
1.4.4 Combination Hemostats
1.4.5 Gelatin Based Hemostats
1.4.6 Collagen Based Hemostats
1.5 Market by Application
1.5.1 Global Hemostats Market Size Growth Rate by Application
1.5.2 Prehospital Treatment
1.5.3 Hospital Treatment
1.6 Coronavirus Disease 2019 (Covid-19): Hemostats Industry Impact
1.6.1 How the Covid-19 is Affecting the Hemostats Industry
1.6.1.1 Hemostats Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Hemostats Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Hemostats Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Hemostats Market Size Estimates and Forecasts
2.1.1 Global Hemostats Revenue Estimates and Forecasts 2015-2026
2.1.2 Global Hemostats Production Capacity Estimates and Forecasts 2015-2026
2.1.3 Global Hemostats Production Estimates and Forecasts 2015-2026
2.2 Global Hemostats Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Analysis of Competitive Landscape
2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
2.3.2 Global Hemostats Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.3.3 Global Hemostats Manufacturers Geographical Distribution
2.4 Key Trends for Hemostats Markets & Products
2.5 Primary Interviews with Key Hemostats Players (Opinion Leaders)
3 MARKET SIZE BY MANUFACTURERS
3.1 Global Top Hemostats Manufacturers by Production Capacity
3.1.1 Global Top Hemostats Manufacturers by Production Capacity (2015-2020)
3.1.2 Global Top Hemostats Manufacturers by Production (2015-2020)
3.1.3 Global Top Hemostats Manufacturers Market Share by Production
3.2 Global Top Hemostats Manufacturers by Revenue
3.2.1 Global Top Hemostats Manufacturers by Revenue (2015-2020)
3.2.2 Global Top Hemostats Manufacturers Market Share by Revenue (2015-2020)
3.2.3 Global Top 10 and Top 5 Companies by Hemostats Revenue in 2019
3.3 Global Hemostats Price by Manufacturers
3.4 Mergers & Acquisitions, Expansion Plans
4 HEMOSTATS PRODUCTION BY REGIONS
4.1 Global Hemostats Historic Market Facts & Figures by Regions
4.1.1 Global Top Hemostats Regions by Production (2015-2020)
4.1.2 Global Top Hemostats Regions by Revenue (2015-2020)
4.2 North America
4.2.1 North America Hemostats Production (2015-2020)
4.2.2 North America Hemostats Revenue (2015-2020)
4.2.3 Key Players in North America
4.2.4 North America Hemostats Import & Export (2015-2020)
4.3 Europe
4.3.1 Europe Hemostats Production (2015-2020)
4.3.2 Europe Hemostats Revenue (2015-2020)
4.3.3 Key Players in Europe
4.3.4 Europe Hemostats Import & Export (2015-2020)
4.4 China
4.4.1 China Hemostats Production (2015-2020)
4.4.2 China Hemostats Revenue (2015-2020)
4.4.3 Key Players in China
4.4.4 China Hemostats Import & Export (2015-2020)
4.5 Japan
4.5.1 Japan Hemostats Production (2015-2020)
4.5.2 Japan Hemostats Revenue (2015-2020)
4.5.3 Key Players in Japan
4.5.4 Japan Hemostats Import & Export (2015-2020)
5 HEMOSTATS CONSUMPTION BY REGION
5.1 Global Top Hemostats Regions by Consumption
5.1.1 Global Top Hemostats Regions by Consumption (2015-2020)
5.1.2 Global Top Hemostats Regions Market Share by Consumption (2015-2020)
5.2 North America
5.2.1 North America Hemostats Consumption by Application
5.2.2 North America Hemostats Consumption by Countries
5.2.3 U.S.
5.2.4 Canada
5.3 Europe
5.3.1 Europe Hemostats Consumption by Application
5.3.2 Europe Hemostats Consumption by Countries
5.3.3 Germany
5.3.4 France
5.3.5 U.K.
5.3.6 Italy
5.3.7 Russia
5.4 Asia Pacific
5.4.1 Asia Pacific Hemostats Consumption by Application
5.4.2 Asia Pacific Hemostats Consumption by Regions
5.4.3 China
5.4.4 Japan
5.4.5 South Korea
5.4.6 India
5.4.7 Australia
5.4.8 Taiwan
5.4.9 Indonesia
5.4.10 Thailand
5.4.11 Malaysia
5.4.12 Philippines
5.4.13 Vietnam
5.5 Central & South America
5.5.1 Central & South America Hemostats Consumption by Application
5.5.2 Central & South America Hemostats Consumption by Country
5.5.3 Mexico
5.5.3 Brazil
5.5.3 Argentina
5.6 Middle East and Africa
5.6.1 Middle East and Africa Hemostats Consumption by Application
5.6.2 Middle East and Africa Hemostats Consumption by Countries
5.6.3 Turkey
5.6.4 Saudi Arabia
5.6.5 UAE
6 MARKET SIZE BY TYPE (2015-2026)
6.1 Global Hemostats Market Size by Type (2015-2020)
6.1.1 Global Hemostats Production by Type (2015-2020)
6.1.2 Global Hemostats Revenue by Type (2015-2020)
6.1.3 Hemostats Price by Type (2015-2020)
6.2 Global Hemostats Market Forecast by Type (2021-2026)
6.2.1 Global Hemostats Production Forecast by Type (2021-2026)
6.2.2 Global Hemostats Revenue Forecast by Type (2021-2026)
6.2.3 Global Hemostats Price Forecast by Type (2021-2026)
6.3 Global Hemostats Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
7 MARKET SIZE BY APPLICATION (2015-2026)
7.2.1 Global Hemostats Consumption Historic Breakdown by Application (2015-2020)
7.2.2 Global Hemostats Consumption Forecast by Application (2021-2026)
8 CORPORATE PROFILES
8.1 Ethicon
8.1.1 Ethicon Corporation Information
8.1.2 Ethicon Overview and Its Total Revenue
8.1.3 Ethicon Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.1.4 Ethicon Product Description
8.1.5 Ethicon Recent Development
8.2 Pfizer
8.2.1 Pfizer Corporation Information
8.2.2 Pfizer Overview and Its Total Revenue
8.2.3 Pfizer Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.2.4 Pfizer Product Description
8.2.5 Pfizer Recent Development
8.3 Baxter International Inc.
8.3.1 Baxter International Inc. Corporation Information
8.3.2 Baxter International Inc. Overview and Its Total Revenue
8.3.3 Baxter International Inc. Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.3.4 Baxter International Inc. Product Description
8.3.5 Baxter International Inc. Recent Development
8.4 C. R. Bard
8.4.1 C. R. Bard Corporation Information
8.4.2 C. R. Bard Overview and Its Total Revenue
8.4.3 C. R. Bard Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.4.4 C. R. Bard Product Description
8.4.5 C. R. Bard Recent Development
8.5 The Medicines Company
8.5.1 The Medicines Company Corporation Information
8.5.2 The Medicines Company Overview and Its Total Revenue
8.5.3 The Medicines Company Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.5.4 The Medicines Company Product Description
8.5.5 The Medicines Company Recent Development
8.6 Anika Therapeutics
8.6.1 Anika Therapeutics Corporation Information
8.6.2 Anika Therapeutics Overview and Its Total Revenue
8.6.3 Anika Therapeutics Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.6.4 Anika Therapeutics Product Description
8.6.5 Anika Therapeutics Recent Development
8.7 Advanced Medical Solutions
8.7.1 Advanced Medical Solutions Corporation Information
8.7.2 Advanced Medical Solutions Overview and Its Total Revenue
8.7.3 Advanced Medical Solutions Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.7.4 Advanced Medical Solutions Product Description
8.7.5 Advanced Medical Solutions Recent Development
8.8 Integra LifeSciences Corporation
8.8.1 Integra LifeSciences Corporation Corporation Information
8.8.2 Integra LifeSciences Corporation Overview and Its Total Revenue
8.8.3 Integra LifeSciences Corporation Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.8.4 Integra LifeSciences Corporation Product Description
8.8.5 Integra LifeSciences Corporation Recent Development
8.9 B Braun Melsungen AG
8.9.1 B Braun Melsungen AG Corporation Information
8.9.2 B Braun Melsungen AG Overview and Its Total Revenue
8.9.3 B Braun Melsungen AG Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.9.4 B Braun Melsungen AG Product Description
8.9.5 B Braun Melsungen AG Recent Development
8.10 Gelita Medical GmbH
8.10.1 Gelita Medical GmbH Corporation Information
8.10.2 Gelita Medical GmbH Overview and Its Total Revenue
8.10.3 Gelita Medical GmbH Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.10.4 Gelita Medical GmbH Product Description
8.10.5 Gelita Medical GmbH Recent Development
8.11 Equimedical
8.11.1 Equimedical Corporation Information
8.11.2 Equimedical Overview and Its Total Revenue
8.11.3 Equimedical Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.11.4 Equimedical Product Description
8.11.5 Equimedical Recent Development
8.12 Vascular Solutions
8.12.1 Vascular Solutions Corporation Information
8.12.2 Vascular Solutions Overview and Its Total Revenue
8.12.3 Vascular Solutions Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.12.4 Vascular Solutions Product Description
8.12.5 Vascular Solutions Recent Development
8.13 Marine Polymer Technologies
8.13.1 Marine Polymer Technologies Corporation Information
8.13.2 Marine Polymer Technologies Overview and Its Total Revenue
8.13.3 Marine Polymer Technologies Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.13.4 Marine Polymer Technologies Product Description
8.13.5 Marine Polymer Technologies Recent Development
8.14 Z-Medica, LLC
8.14.1 Z-Medica, LLC Corporation Information
8.14.2 Z-Medica, LLC Overview and Its Total Revenue
8.14.3 Z-Medica, LLC Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.14.4 Z-Medica, LLC Product Description
8.14.5 Z-Medica, LLC Recent Development
8.15 CryoLife
8.15.1 CryoLife Corporation Information
8.15.2 CryoLife Overview and Its Total Revenue
8.15.3 CryoLife Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.15.4 CryoLife Product Description
8.15.5 CryoLife Recent Development
8.16 BioCer Entwicklungs-GmbH.
8.16.1 BioCer Entwicklungs-GmbH. Corporation Information
8.16.2 BioCer Entwicklungs-GmbH. Overview and Its Total Revenue
8.16.3 BioCer Entwicklungs-GmbH. Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.16.4 BioCer Entwicklungs-GmbH. Product Description
8.16.5 BioCer Entwicklungs-GmbH. Recent Development
8.17 Biom'Up SAS
8.17.1 Biom'Up SAS Corporation Information
8.17.2 Biom'Up SAS Overview and Its Total Revenue
8.17.3 Biom'Up SAS Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.17.4 Biom'Up SAS Product Description
8.17.5 Biom'Up SAS Recent Development
9 PRODUCTION FORECASTS BY REGIONS
9.1 Global Top Hemostats Regions Forecast by Revenue (2021-2026)
9.2 Global Top Hemostats Regions Forecast by Production (2021-2026)
9.3 Key Hemostats Production Regions Forecast
9.3.1 North America
9.3.2 Europe
9.3.3 China
9.3.4 Japan
10 HEMOSTATS CONSUMPTION FORECAST BY REGION
10.1 Global Hemostats Consumption Forecast by Region (2021-2026)
10.2 North America Hemostats Consumption Forecast by Region (2021-2026)
10.3 Europe Hemostats Consumption Forecast by Region (2021-2026)
10.4 Asia Pacific Hemostats Consumption Forecast by Region (2021-2026)
10.5 Latin America Hemostats Consumption Forecast by Region (2021-2026)
10.6 Middle East and Africa Hemostats Consumption Forecast by Region (2021-2026)
11 VALUE CHAIN AND SALES CHANNELS ANALYSIS
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Hemostats Sales Channels
11.2.2 Hemostats Distributors
11.3 Hemostats Customers
12 MARKET OPPORTUNITIES & CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Porter's Five Forces Analysis
13 KEY FINDING IN THE GLOBAL HEMOSTATS STUDY
14 APPENDIX
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
1.1 Hemostats Product Introduction
1.2 Key Market Segments in This Study
1.3 Key Manufacturers Covered: Ranking of Global Top Hemostats Manufacturers by Revenue in 2019
1.4 Market by Type
1.4.1 Global Hemostats Market Size Growth Rate by Type
1.4.2 Thrombin-Based Hemostats
1.4.3 Oxidized Regenerated Cellulose Based Hemostats
1.4.4 Combination Hemostats
1.4.5 Gelatin Based Hemostats
1.4.6 Collagen Based Hemostats
1.5 Market by Application
1.5.1 Global Hemostats Market Size Growth Rate by Application
1.5.2 Prehospital Treatment
1.5.3 Hospital Treatment
1.6 Coronavirus Disease 2019 (Covid-19): Hemostats Industry Impact
1.6.1 How the Covid-19 is Affecting the Hemostats Industry
1.6.1.1 Hemostats Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Hemostats Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Hemostats Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Hemostats Market Size Estimates and Forecasts
2.1.1 Global Hemostats Revenue Estimates and Forecasts 2015-2026
2.1.2 Global Hemostats Production Capacity Estimates and Forecasts 2015-2026
2.1.3 Global Hemostats Production Estimates and Forecasts 2015-2026
2.2 Global Hemostats Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Analysis of Competitive Landscape
2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
2.3.2 Global Hemostats Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.3.3 Global Hemostats Manufacturers Geographical Distribution
2.4 Key Trends for Hemostats Markets & Products
2.5 Primary Interviews with Key Hemostats Players (Opinion Leaders)
3 MARKET SIZE BY MANUFACTURERS
3.1 Global Top Hemostats Manufacturers by Production Capacity
3.1.1 Global Top Hemostats Manufacturers by Production Capacity (2015-2020)
3.1.2 Global Top Hemostats Manufacturers by Production (2015-2020)
3.1.3 Global Top Hemostats Manufacturers Market Share by Production
3.2 Global Top Hemostats Manufacturers by Revenue
3.2.1 Global Top Hemostats Manufacturers by Revenue (2015-2020)
3.2.2 Global Top Hemostats Manufacturers Market Share by Revenue (2015-2020)
3.2.3 Global Top 10 and Top 5 Companies by Hemostats Revenue in 2019
3.3 Global Hemostats Price by Manufacturers
3.4 Mergers & Acquisitions, Expansion Plans
4 HEMOSTATS PRODUCTION BY REGIONS
4.1 Global Hemostats Historic Market Facts & Figures by Regions
4.1.1 Global Top Hemostats Regions by Production (2015-2020)
4.1.2 Global Top Hemostats Regions by Revenue (2015-2020)
4.2 North America
4.2.1 North America Hemostats Production (2015-2020)
4.2.2 North America Hemostats Revenue (2015-2020)
4.2.3 Key Players in North America
4.2.4 North America Hemostats Import & Export (2015-2020)
4.3 Europe
4.3.1 Europe Hemostats Production (2015-2020)
4.3.2 Europe Hemostats Revenue (2015-2020)
4.3.3 Key Players in Europe
4.3.4 Europe Hemostats Import & Export (2015-2020)
4.4 China
4.4.1 China Hemostats Production (2015-2020)
4.4.2 China Hemostats Revenue (2015-2020)
4.4.3 Key Players in China
4.4.4 China Hemostats Import & Export (2015-2020)
4.5 Japan
4.5.1 Japan Hemostats Production (2015-2020)
4.5.2 Japan Hemostats Revenue (2015-2020)
4.5.3 Key Players in Japan
4.5.4 Japan Hemostats Import & Export (2015-2020)
5 HEMOSTATS CONSUMPTION BY REGION
5.1 Global Top Hemostats Regions by Consumption
5.1.1 Global Top Hemostats Regions by Consumption (2015-2020)
5.1.2 Global Top Hemostats Regions Market Share by Consumption (2015-2020)
5.2 North America
5.2.1 North America Hemostats Consumption by Application
5.2.2 North America Hemostats Consumption by Countries
5.2.3 U.S.
5.2.4 Canada
5.3 Europe
5.3.1 Europe Hemostats Consumption by Application
5.3.2 Europe Hemostats Consumption by Countries
5.3.3 Germany
5.3.4 France
5.3.5 U.K.
5.3.6 Italy
5.3.7 Russia
5.4 Asia Pacific
5.4.1 Asia Pacific Hemostats Consumption by Application
5.4.2 Asia Pacific Hemostats Consumption by Regions
5.4.3 China
5.4.4 Japan
5.4.5 South Korea
5.4.6 India
5.4.7 Australia
5.4.8 Taiwan
5.4.9 Indonesia
5.4.10 Thailand
5.4.11 Malaysia
5.4.12 Philippines
5.4.13 Vietnam
5.5 Central & South America
5.5.1 Central & South America Hemostats Consumption by Application
5.5.2 Central & South America Hemostats Consumption by Country
5.5.3 Mexico
5.5.3 Brazil
5.5.3 Argentina
5.6 Middle East and Africa
5.6.1 Middle East and Africa Hemostats Consumption by Application
5.6.2 Middle East and Africa Hemostats Consumption by Countries
5.6.3 Turkey
5.6.4 Saudi Arabia
5.6.5 UAE
6 MARKET SIZE BY TYPE (2015-2026)
6.1 Global Hemostats Market Size by Type (2015-2020)
6.1.1 Global Hemostats Production by Type (2015-2020)
6.1.2 Global Hemostats Revenue by Type (2015-2020)
6.1.3 Hemostats Price by Type (2015-2020)
6.2 Global Hemostats Market Forecast by Type (2021-2026)
6.2.1 Global Hemostats Production Forecast by Type (2021-2026)
6.2.2 Global Hemostats Revenue Forecast by Type (2021-2026)
6.2.3 Global Hemostats Price Forecast by Type (2021-2026)
6.3 Global Hemostats Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
7 MARKET SIZE BY APPLICATION (2015-2026)
7.2.1 Global Hemostats Consumption Historic Breakdown by Application (2015-2020)
7.2.2 Global Hemostats Consumption Forecast by Application (2021-2026)
8 CORPORATE PROFILES
8.1 Ethicon
8.1.1 Ethicon Corporation Information
8.1.2 Ethicon Overview and Its Total Revenue
8.1.3 Ethicon Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.1.4 Ethicon Product Description
8.1.5 Ethicon Recent Development
8.2 Pfizer
8.2.1 Pfizer Corporation Information
8.2.2 Pfizer Overview and Its Total Revenue
8.2.3 Pfizer Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.2.4 Pfizer Product Description
8.2.5 Pfizer Recent Development
8.3 Baxter International Inc.
8.3.1 Baxter International Inc. Corporation Information
8.3.2 Baxter International Inc. Overview and Its Total Revenue
8.3.3 Baxter International Inc. Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.3.4 Baxter International Inc. Product Description
8.3.5 Baxter International Inc. Recent Development
8.4 C. R. Bard
8.4.1 C. R. Bard Corporation Information
8.4.2 C. R. Bard Overview and Its Total Revenue
8.4.3 C. R. Bard Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.4.4 C. R. Bard Product Description
8.4.5 C. R. Bard Recent Development
8.5 The Medicines Company
8.5.1 The Medicines Company Corporation Information
8.5.2 The Medicines Company Overview and Its Total Revenue
8.5.3 The Medicines Company Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.5.4 The Medicines Company Product Description
8.5.5 The Medicines Company Recent Development
8.6 Anika Therapeutics
8.6.1 Anika Therapeutics Corporation Information
8.6.2 Anika Therapeutics Overview and Its Total Revenue
8.6.3 Anika Therapeutics Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.6.4 Anika Therapeutics Product Description
8.6.5 Anika Therapeutics Recent Development
8.7 Advanced Medical Solutions
8.7.1 Advanced Medical Solutions Corporation Information
8.7.2 Advanced Medical Solutions Overview and Its Total Revenue
8.7.3 Advanced Medical Solutions Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.7.4 Advanced Medical Solutions Product Description
8.7.5 Advanced Medical Solutions Recent Development
8.8 Integra LifeSciences Corporation
8.8.1 Integra LifeSciences Corporation Corporation Information
8.8.2 Integra LifeSciences Corporation Overview and Its Total Revenue
8.8.3 Integra LifeSciences Corporation Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.8.4 Integra LifeSciences Corporation Product Description
8.8.5 Integra LifeSciences Corporation Recent Development
8.9 B Braun Melsungen AG
8.9.1 B Braun Melsungen AG Corporation Information
8.9.2 B Braun Melsungen AG Overview and Its Total Revenue
8.9.3 B Braun Melsungen AG Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.9.4 B Braun Melsungen AG Product Description
8.9.5 B Braun Melsungen AG Recent Development
8.10 Gelita Medical GmbH
8.10.1 Gelita Medical GmbH Corporation Information
8.10.2 Gelita Medical GmbH Overview and Its Total Revenue
8.10.3 Gelita Medical GmbH Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.10.4 Gelita Medical GmbH Product Description
8.10.5 Gelita Medical GmbH Recent Development
8.11 Equimedical
8.11.1 Equimedical Corporation Information
8.11.2 Equimedical Overview and Its Total Revenue
8.11.3 Equimedical Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.11.4 Equimedical Product Description
8.11.5 Equimedical Recent Development
8.12 Vascular Solutions
8.12.1 Vascular Solutions Corporation Information
8.12.2 Vascular Solutions Overview and Its Total Revenue
8.12.3 Vascular Solutions Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.12.4 Vascular Solutions Product Description
8.12.5 Vascular Solutions Recent Development
8.13 Marine Polymer Technologies
8.13.1 Marine Polymer Technologies Corporation Information
8.13.2 Marine Polymer Technologies Overview and Its Total Revenue
8.13.3 Marine Polymer Technologies Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.13.4 Marine Polymer Technologies Product Description
8.13.5 Marine Polymer Technologies Recent Development
8.14 Z-Medica, LLC
8.14.1 Z-Medica, LLC Corporation Information
8.14.2 Z-Medica, LLC Overview and Its Total Revenue
8.14.3 Z-Medica, LLC Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.14.4 Z-Medica, LLC Product Description
8.14.5 Z-Medica, LLC Recent Development
8.15 CryoLife
8.15.1 CryoLife Corporation Information
8.15.2 CryoLife Overview and Its Total Revenue
8.15.3 CryoLife Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.15.4 CryoLife Product Description
8.15.5 CryoLife Recent Development
8.16 BioCer Entwicklungs-GmbH.
8.16.1 BioCer Entwicklungs-GmbH. Corporation Information
8.16.2 BioCer Entwicklungs-GmbH. Overview and Its Total Revenue
8.16.3 BioCer Entwicklungs-GmbH. Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.16.4 BioCer Entwicklungs-GmbH. Product Description
8.16.5 BioCer Entwicklungs-GmbH. Recent Development
8.17 Biom'Up SAS
8.17.1 Biom'Up SAS Corporation Information
8.17.2 Biom'Up SAS Overview and Its Total Revenue
8.17.3 Biom'Up SAS Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.17.4 Biom'Up SAS Product Description
8.17.5 Biom'Up SAS Recent Development
9 PRODUCTION FORECASTS BY REGIONS
9.1 Global Top Hemostats Regions Forecast by Revenue (2021-2026)
9.2 Global Top Hemostats Regions Forecast by Production (2021-2026)
9.3 Key Hemostats Production Regions Forecast
9.3.1 North America
9.3.2 Europe
9.3.3 China
9.3.4 Japan
10 HEMOSTATS CONSUMPTION FORECAST BY REGION
10.1 Global Hemostats Consumption Forecast by Region (2021-2026)
10.2 North America Hemostats Consumption Forecast by Region (2021-2026)
10.3 Europe Hemostats Consumption Forecast by Region (2021-2026)
10.4 Asia Pacific Hemostats Consumption Forecast by Region (2021-2026)
10.5 Latin America Hemostats Consumption Forecast by Region (2021-2026)
10.6 Middle East and Africa Hemostats Consumption Forecast by Region (2021-2026)
11 VALUE CHAIN AND SALES CHANNELS ANALYSIS
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Hemostats Sales Channels
11.2.2 Hemostats Distributors
11.3 Hemostats Customers
12 MARKET OPPORTUNITIES & CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Porter's Five Forces Analysis
13 KEY FINDING IN THE GLOBAL HEMOSTATS STUDY
14 APPENDIX
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
LIST OF TABLES
Table 1. Hemostats Key Market Segments in This Study
Table 2. Ranking of Global Top Hemostats Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Hemostats Market Size Growth Rate by Type 2020-2026 (K Pcs) (Million US$)
Table 4. Major Manufacturers of Thrombin-Based Hemostats
Table 5. Major Manufacturers of Oxidized Regenerated Cellulose Based Hemostats
Table 6. Major Manufacturers of Combination Hemostats
Table 7. Major Manufacturers of Gelatin Based Hemostats
Table 8. Major Manufacturers of Collagen Based Hemostats
Table 9. COVID-19 Impact Global Market: (Four Hemostats Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Hemostats Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Hemostats Players to Combat Covid-19 Impact
Table 14. Global Hemostats Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 15. Global Hemostats Market Size by Region in US$ Million: 2015 VS 2020 VS 2026
Table 16. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Hemostats by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hemostats as of 2019)
Table 18. Hemostats Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Hemostats Product Offered
Table 20. Date of Manufacturers Enter into Hemostats Market
Table 21. Key Trends for Hemostats Markets & Products
Table 22. Main Points Interviewed from Key Hemostats Players
Table 23. Global Hemostats Production Capacity by Manufacturers (2015-2020) (K Pcs)
Table 24. Global Hemostats Production Share by Manufacturers (2015-2020)
Table 25. Hemostats Revenue by Manufacturers (2015-2020) (Million US$)
Table 26. Hemostats Revenue Share by Manufacturers (2015-2020)
Table 27. Hemostats Price by Manufacturers 2015-2020 (USD/Pcs)
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Hemostats Production by Regions (2015-2020) (K Pcs)
Table 30. Global Hemostats Production Market Share by Regions (2015-2020)
Table 31. Global Hemostats Revenue by Regions (2015-2020) (US$ Million)
Table 32. Global Hemostats Revenue Market Share by Regions (2015-2020)
Table 33. Key Hemostats Players in North America
Table 34. Import & Export of Hemostats in North America (K Pcs)
Table 35. Key Hemostats Players in Europe
Table 36. Import & Export of Hemostats in Europe (K Pcs)
Table 37. Key Hemostats Players in China
Table 38. Import & Export of Hemostats in China (K Pcs)
Table 39. Key Hemostats Players in Japan
Table 40. Import & Export of Hemostats in Japan (K Pcs)
Table 41. Global Hemostats Consumption by Regions (2015-2020) (K Pcs)
Table 42. Global Hemostats Consumption Market Share by Regions (2015-2020)
Table 43. North America Hemostats Consumption by Application (2015-2020) (K Pcs)
Table 44. North America Hemostats Consumption by Countries (2015-2020) (K Pcs)
Table 45. Europe Hemostats Consumption by Application (2015-2020) (K Pcs)
Table 46. Europe Hemostats Consumption by Countries (2015-2020) (K Pcs)
Table 47. Asia Pacific Hemostats Consumption by Application (2015-2020) (K Pcs)
Table 48. Asia Pacific Hemostats Consumption Market Share by Application (2015-2020) (K Pcs)
Table 49. Asia Pacific Hemostats Consumption by Regions (2015-2020) (K Pcs)
Table 50. Latin America Hemostats Consumption by Application (2015-2020) (K Pcs)
Table 51. Latin America Hemostats Consumption by Countries (2015-2020) (K Pcs)
Table 52. Middle East and Africa Hemostats Consumption by Application (2015-2020) (K Pcs)
Table 53. Middle East and Africa Hemostats Consumption by Countries (2015-2020) (K Pcs)
Table 54. Global Hemostats Production by Type (2015-2020) (K Pcs)
Table 55. Global Hemostats Production Share by Type (2015-2020)
Table 56. Global Hemostats Revenue by Type (2015-2020) (Million US$)
Table 57. Global Hemostats Revenue Share by Type (2015-2020)
Table 58. Hemostats Price by Type 2015-2020 (USD/Pcs)
Table 59. Global Hemostats Consumption by Application (2015-2020) (K Pcs)
Table 60. Global Hemostats Consumption by Application (2015-2020) (K Pcs)
Table 61. Global Hemostats Consumption Share by Application (2015-2020)
Table 62. Ethicon Corporation Information
Table 63. Ethicon Description and Major Businesses
Table 64. Ethicon Hemostats Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 65. Ethicon Product
Table 66. Ethicon Recent Development
Table 67. Pfizer Corporation Information
Table 68. Pfizer Description and Major Businesses
Table 69. Pfizer Hemostats Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 70. Pfizer Product
Table 71. Pfizer Recent Development
Table 72. Baxter International Inc. Corporation Information
Table 73. Baxter International Inc. Description and Major Businesses
Table 74. Baxter International Inc. Hemostats Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 75. Baxter International Inc. Product
Table 76. Baxter International Inc. Recent Development
Table 77. C. R. Bard Corporation Information
Table 78. C. R. Bard Description and Major Businesses
Table 79. C. R. Bard Hemostats Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. C. R. Bard Product
Table 81. C. R. Bard Recent Development
Table 82. The Medicines Company Corporation Information
Table 83. The Medicines Company Description and Major Businesses
Table 84. The Medicines Company Hemostats Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. The Medicines Company Product
Table 86. The Medicines Company Recent Development
Table 87. Anika Therapeutics Corporation Information
Table 88. Anika Therapeutics Description and Major Businesses
Table 89. Anika Therapeutics Hemostats Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 90. Anika Therapeutics Product
Table 91. Anika Therapeutics Recent Development
Table 92. Advanced Medical Solutions Corporation Information
Table 93. Advanced Medical Solutions Description and Major Businesses
Table 94. Advanced Medical Solutions Hemostats Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 95. Advanced Medical Solutions Product
Table 96. Advanced Medical Solutions Recent Development
Table 97. Integra LifeSciences Corporation Corporation Information
Table 98. Integra LifeSciences Corporation Description and Major Businesses
Table 99. Integra LifeSciences Corporation Hemostats Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 100. Integra LifeSciences Corporation Product
Table 101. Integra LifeSciences Corporation Recent Development
Table 102. B Braun Melsungen AG Corporation Information
Table 103. B Braun Melsungen AG Description and Major Businesses
Table 104. B Braun Melsungen AG Hemostats Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 105. B Braun Melsungen AG Product
Table 106. B Braun Melsungen AG Recent Development
Table 107. Gelita Medical GmbH Corporation Information
Table 108. Gelita Medical GmbH Description and Major Businesses
Table 109. Gelita Medical GmbH Hemostats Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 110. Gelita Medical GmbH Product
Table 111. Gelita Medical GmbH Recent Development
Table 112. Equimedical Corporation Information
Table 113. Equimedical Description and Major Businesses
Table 114. Equimedical Hemostats Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 115. Equimedical Product
Table 116. Equimedical Recent Development
Table 117. Vascular Solutions Corporation Information
Table 118. Vascular Solutions Description and Major Businesses
Table 119. Vascular Solutions Hemostats Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 120. Vascular Solutions Product
Table 121. Vascular Solutions Recent Development
Table 122. Marine Polymer Technologies Corporation Information
Table 123. Marine Polymer Technologies Description and Major Businesses
Table 124. Marine Polymer Technologies Hemostats Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 125. Marine Polymer Technologies Product
Table 126. Marine Polymer Technologies Recent Development
Table 127. Z-Medica, LLC Corporation Information
Table 128. Z-Medica, LLC Description and Major Businesses
Table 129. Z-Medica, LLC Hemostats Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 130. Z-Medica, LLC Product
Table 131. Z-Medica, LLC Recent Development
Table 132. CryoLife Corporation Information
Table 133. CryoLife Description and Major Businesses
Table 134. CryoLife Hemostats Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 135. CryoLife Product
Table 136. CryoLife Recent Development
Table 137. BioCer Entwicklungs-GmbH. Corporation Information
Table 138. BioCer Entwicklungs-GmbH. Description and Major Businesses
Table 139. BioCer Entwicklungs-GmbH. Hemostats Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 140. BioCer Entwicklungs-GmbH. Product
Table 141. BioCer Entwicklungs-GmbH. Recent Development
Table 142. Biom'Up SAS Corporation Information
Table 143. Biom'Up SAS Description and Major Businesses
Table 144. Biom'Up SAS Hemostats Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 145. Biom'Up SAS Product
Table 146. Biom'Up SAS Recent Development
Table 147. Global Hemostats Revenue Forecast by Region (2021-2026) (Million US$)
Table 148. Global Hemostats Production Forecast by Regions (2021-2026) (K Pcs)
Table 149. Global Hemostats Production Forecast by Type (2021-2026) (K Pcs)
Table 150. Global Hemostats Revenue Forecast by Type (2021-2026) (Million US$)
Table 151. North America Hemostats Consumption Forecast by Regions (2021-2026) (K Pcs)
Table 152. Europe Hemostats Consumption Forecast by Regions (2021-2026) (K Pcs)
Table 153. Asia Pacific Hemostats Consumption Forecast by Regions (2021-2026) (K Pcs)
Table 154. Latin America Hemostats Consumption Forecast by Regions (2021-2026) (K Pcs)
Table 155. Middle East and Africa Hemostats Consumption Forecast by Regions (2021-2026) (K Pcs)
Table 156. Hemostats Distributors List
Table 157. Hemostats Customers List
Table 158. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 159. Key Challenges
Table 160. Market Risks
Table 161. Research Programs/Design for This Report
Table 162. Key Data Information from Secondary Sources
Table 163. Key Data Information from Primary Sources
Table 1. Hemostats Key Market Segments in This Study
Table 2. Ranking of Global Top Hemostats Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Hemostats Market Size Growth Rate by Type 2020-2026 (K Pcs) (Million US$)
Table 4. Major Manufacturers of Thrombin-Based Hemostats
Table 5. Major Manufacturers of Oxidized Regenerated Cellulose Based Hemostats
Table 6. Major Manufacturers of Combination Hemostats
Table 7. Major Manufacturers of Gelatin Based Hemostats
Table 8. Major Manufacturers of Collagen Based Hemostats
Table 9. COVID-19 Impact Global Market: (Four Hemostats Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Hemostats Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Hemostats Players to Combat Covid-19 Impact
Table 14. Global Hemostats Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 15. Global Hemostats Market Size by Region in US$ Million: 2015 VS 2020 VS 2026
Table 16. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Hemostats by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hemostats as of 2019)
Table 18. Hemostats Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Hemostats Product Offered
Table 20. Date of Manufacturers Enter into Hemostats Market
Table 21. Key Trends for Hemostats Markets & Products
Table 22. Main Points Interviewed from Key Hemostats Players
Table 23. Global Hemostats Production Capacity by Manufacturers (2015-2020) (K Pcs)
Table 24. Global Hemostats Production Share by Manufacturers (2015-2020)
Table 25. Hemostats Revenue by Manufacturers (2015-2020) (Million US$)
Table 26. Hemostats Revenue Share by Manufacturers (2015-2020)
Table 27. Hemostats Price by Manufacturers 2015-2020 (USD/Pcs)
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Hemostats Production by Regions (2015-2020) (K Pcs)
Table 30. Global Hemostats Production Market Share by Regions (2015-2020)
Table 31. Global Hemostats Revenue by Regions (2015-2020) (US$ Million)
Table 32. Global Hemostats Revenue Market Share by Regions (2015-2020)
Table 33. Key Hemostats Players in North America
Table 34. Import & Export of Hemostats in North America (K Pcs)
Table 35. Key Hemostats Players in Europe
Table 36. Import & Export of Hemostats in Europe (K Pcs)
Table 37. Key Hemostats Players in China
Table 38. Import & Export of Hemostats in China (K Pcs)
Table 39. Key Hemostats Players in Japan
Table 40. Import & Export of Hemostats in Japan (K Pcs)
Table 41. Global Hemostats Consumption by Regions (2015-2020) (K Pcs)
Table 42. Global Hemostats Consumption Market Share by Regions (2015-2020)
Table 43. North America Hemostats Consumption by Application (2015-2020) (K Pcs)
Table 44. North America Hemostats Consumption by Countries (2015-2020) (K Pcs)
Table 45. Europe Hemostats Consumption by Application (2015-2020) (K Pcs)
Table 46. Europe Hemostats Consumption by Countries (2015-2020) (K Pcs)
Table 47. Asia Pacific Hemostats Consumption by Application (2015-2020) (K Pcs)
Table 48. Asia Pacific Hemostats Consumption Market Share by Application (2015-2020) (K Pcs)
Table 49. Asia Pacific Hemostats Consumption by Regions (2015-2020) (K Pcs)
Table 50. Latin America Hemostats Consumption by Application (2015-2020) (K Pcs)
Table 51. Latin America Hemostats Consumption by Countries (2015-2020) (K Pcs)
Table 52. Middle East and Africa Hemostats Consumption by Application (2015-2020) (K Pcs)
Table 53. Middle East and Africa Hemostats Consumption by Countries (2015-2020) (K Pcs)
Table 54. Global Hemostats Production by Type (2015-2020) (K Pcs)
Table 55. Global Hemostats Production Share by Type (2015-2020)
Table 56. Global Hemostats Revenue by Type (2015-2020) (Million US$)
Table 57. Global Hemostats Revenue Share by Type (2015-2020)
Table 58. Hemostats Price by Type 2015-2020 (USD/Pcs)
Table 59. Global Hemostats Consumption by Application (2015-2020) (K Pcs)
Table 60. Global Hemostats Consumption by Application (2015-2020) (K Pcs)
Table 61. Global Hemostats Consumption Share by Application (2015-2020)
Table 62. Ethicon Corporation Information
Table 63. Ethicon Description and Major Businesses
Table 64. Ethicon Hemostats Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 65. Ethicon Product
Table 66. Ethicon Recent Development
Table 67. Pfizer Corporation Information
Table 68. Pfizer Description and Major Businesses
Table 69. Pfizer Hemostats Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 70. Pfizer Product
Table 71. Pfizer Recent Development
Table 72. Baxter International Inc. Corporation Information
Table 73. Baxter International Inc. Description and Major Businesses
Table 74. Baxter International Inc. Hemostats Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 75. Baxter International Inc. Product
Table 76. Baxter International Inc. Recent Development
Table 77. C. R. Bard Corporation Information
Table 78. C. R. Bard Description and Major Businesses
Table 79. C. R. Bard Hemostats Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. C. R. Bard Product
Table 81. C. R. Bard Recent Development
Table 82. The Medicines Company Corporation Information
Table 83. The Medicines Company Description and Major Businesses
Table 84. The Medicines Company Hemostats Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. The Medicines Company Product
Table 86. The Medicines Company Recent Development
Table 87. Anika Therapeutics Corporation Information
Table 88. Anika Therapeutics Description and Major Businesses
Table 89. Anika Therapeutics Hemostats Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 90. Anika Therapeutics Product
Table 91. Anika Therapeutics Recent Development
Table 92. Advanced Medical Solutions Corporation Information
Table 93. Advanced Medical Solutions Description and Major Businesses
Table 94. Advanced Medical Solutions Hemostats Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 95. Advanced Medical Solutions Product
Table 96. Advanced Medical Solutions Recent Development
Table 97. Integra LifeSciences Corporation Corporation Information
Table 98. Integra LifeSciences Corporation Description and Major Businesses
Table 99. Integra LifeSciences Corporation Hemostats Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 100. Integra LifeSciences Corporation Product
Table 101. Integra LifeSciences Corporation Recent Development
Table 102. B Braun Melsungen AG Corporation Information
Table 103. B Braun Melsungen AG Description and Major Businesses
Table 104. B Braun Melsungen AG Hemostats Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 105. B Braun Melsungen AG Product
Table 106. B Braun Melsungen AG Recent Development
Table 107. Gelita Medical GmbH Corporation Information
Table 108. Gelita Medical GmbH Description and Major Businesses
Table 109. Gelita Medical GmbH Hemostats Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 110. Gelita Medical GmbH Product
Table 111. Gelita Medical GmbH Recent Development
Table 112. Equimedical Corporation Information
Table 113. Equimedical Description and Major Businesses
Table 114. Equimedical Hemostats Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 115. Equimedical Product
Table 116. Equimedical Recent Development
Table 117. Vascular Solutions Corporation Information
Table 118. Vascular Solutions Description and Major Businesses
Table 119. Vascular Solutions Hemostats Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 120. Vascular Solutions Product
Table 121. Vascular Solutions Recent Development
Table 122. Marine Polymer Technologies Corporation Information
Table 123. Marine Polymer Technologies Description and Major Businesses
Table 124. Marine Polymer Technologies Hemostats Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 125. Marine Polymer Technologies Product
Table 126. Marine Polymer Technologies Recent Development
Table 127. Z-Medica, LLC Corporation Information
Table 128. Z-Medica, LLC Description and Major Businesses
Table 129. Z-Medica, LLC Hemostats Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 130. Z-Medica, LLC Product
Table 131. Z-Medica, LLC Recent Development
Table 132. CryoLife Corporation Information
Table 133. CryoLife Description and Major Businesses
Table 134. CryoLife Hemostats Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 135. CryoLife Product
Table 136. CryoLife Recent Development
Table 137. BioCer Entwicklungs-GmbH. Corporation Information
Table 138. BioCer Entwicklungs-GmbH. Description and Major Businesses
Table 139. BioCer Entwicklungs-GmbH. Hemostats Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 140. BioCer Entwicklungs-GmbH. Product
Table 141. BioCer Entwicklungs-GmbH. Recent Development
Table 142. Biom'Up SAS Corporation Information
Table 143. Biom'Up SAS Description and Major Businesses
Table 144. Biom'Up SAS Hemostats Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 145. Biom'Up SAS Product
Table 146. Biom'Up SAS Recent Development
Table 147. Global Hemostats Revenue Forecast by Region (2021-2026) (Million US$)
Table 148. Global Hemostats Production Forecast by Regions (2021-2026) (K Pcs)
Table 149. Global Hemostats Production Forecast by Type (2021-2026) (K Pcs)
Table 150. Global Hemostats Revenue Forecast by Type (2021-2026) (Million US$)
Table 151. North America Hemostats Consumption Forecast by Regions (2021-2026) (K Pcs)
Table 152. Europe Hemostats Consumption Forecast by Regions (2021-2026) (K Pcs)
Table 153. Asia Pacific Hemostats Consumption Forecast by Regions (2021-2026) (K Pcs)
Table 154. Latin America Hemostats Consumption Forecast by Regions (2021-2026) (K Pcs)
Table 155. Middle East and Africa Hemostats Consumption Forecast by Regions (2021-2026) (K Pcs)
Table 156. Hemostats Distributors List
Table 157. Hemostats Customers List
Table 158. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 159. Key Challenges
Table 160. Market Risks
Table 161. Research Programs/Design for This Report
Table 162. Key Data Information from Secondary Sources
Table 163. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Hemostats Product Picture
Figure 2. Global Hemostats Production Market Share by Type in 2020 & 2026
Figure 3. Thrombin-Based Hemostats Product Picture
Figure 4. Oxidized Regenerated Cellulose Based Hemostats Product Picture
Figure 5. Combination Hemostats Product Picture
Figure 6. Gelatin Based Hemostats Product Picture
Figure 7. Collagen Based Hemostats Product Picture
Figure 8. Global Hemostats Consumption Market Share by Application in 2020 & 2026
Figure 9. Prehospital Treatment
Figure 10. Hospital Treatment
Figure 11. Hemostats Report Years Considered
Figure 12. Global Hemostats Revenue 2015-2026 (Million US$)
Figure 13. Global Hemostats Production Capacity 2015-2026 (K Pcs)
Figure 14. Global Hemostats Production 2015-2026 (K Pcs)
Figure 15. Global Hemostats Market Share Scenario by Region in Percentage: 2020 Versus 2026
Figure 16. Hemostats Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 17. Global Hemostats Production Share by Manufacturers in 2015
Figure 18. The Top 10 and Top 5 Players Market Share by Hemostats Revenue in 2019
Figure 19. Global Hemostats Production Market Share by Region (2015-2020)
Figure 20. Hemostats Production Growth Rate in North America (2015-2020) (K Pcs)
Figure 21. Hemostats Revenue Growth Rate in North America (2015-2020) (US$ Million)
Figure 22. Hemostats Production Growth Rate in Europe (2015-2020) (K Pcs)
Figure 23. Hemostats Revenue Growth Rate in Europe (2015-2020) (US$ Million)
Figure 24. Hemostats Production Growth Rate in China (2015-2020) (K Pcs)
Figure 25. Hemostats Revenue Growth Rate in China (2015-2020) (US$ Million)
Figure 26. Hemostats Production Growth Rate in Japan (2015-2020) (K Pcs)
Figure 27. Hemostats Revenue Growth Rate in Japan (2015-2020) (US$ Million)
Figure 28. Global Hemostats Consumption Market Share by Regions 2015-2020
Figure 29. North America Hemostats Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 30. North America Hemostats Consumption Market Share by Application in 2019
Figure 31. North America Hemostats Consumption Market Share by Countries in 2019
Figure 32. U.S. Hemostats Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 33. Canada Hemostats Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 34. Europe Hemostats Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 35. Europe Hemostats Consumption Market Share by Application in 2019
Figure 36. Europe Hemostats Consumption Market Share by Countries in 2019
Figure 37. Germany Hemostats Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 38. France Hemostats Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 39. U.K. Hemostats Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 40. Italy Hemostats Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 41. Russia Hemostats Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 42. Asia Pacific Hemostats Consumption and Growth Rate (K Pcs)
Figure 43. Asia Pacific Hemostats Consumption Market Share by Application in 2019
Figure 44. Asia Pacific Hemostats Consumption Market Share by Regions in 2019
Figure 45. China Hemostats Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 46. Japan Hemostats Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 47. South Korea Hemostats Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 48. India Hemostats Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 49. Australia Hemostats Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 50. Taiwan Hemostats Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 51. Indonesia Hemostats Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 52. Thailand Hemostats Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 53. Malaysia Hemostats Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 54. Philippines Hemostats Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 55. Vietnam Hemostats Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 56. Latin America Hemostats Consumption and Growth Rate (K Pcs)
Figure 57. Latin America Hemostats Consumption Market Share by Application in 2019
Figure 58. Latin America Hemostats Consumption Market Share by Countries in 2019
Figure 59. Mexico Hemostats Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 60. Brazil Hemostats Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 61. Argentina Hemostats Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 62. Middle East and Africa Hemostats Consumption and Growth Rate (K Pcs)
Figure 63. Middle East and Africa Hemostats Consumption Market Share by Application in 2019
Figure 64. Middle East and Africa Hemostats Consumption Market Share by Countries in 2019
Figure 65. Turkey Hemostats Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 66. Saudi Arabia Hemostats Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 67. UAE Hemostats Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 68. Global Hemostats Production Market Share by Type (2015-2020)
Figure 69. Global Hemostats Production Market Share by Type in 2019
Figure 70. Global Hemostats Revenue Market Share by Type (2015-2020)
Figure 71. Global Hemostats Revenue Market Share by Type in 2019
Figure 72. Global Hemostats Production Market Share Forecast by Type (2021-2026)
Figure 73. Global Hemostats Revenue Market Share Forecast by Type (2021-2026)
Figure 74. Global Hemostats Market Share by Price Range (2015-2020)
Figure 75. Global Hemostats Consumption Market Share by Application (2015-2020)
Figure 76. Global Hemostats Value (Consumption) Market Share by Application (2015-2020)
Figure 77. Global Hemostats Consumption Market Share Forecast by Application (2021-2026)
Figure 78. Ethicon Total Revenue (US$ Million): 2019 Compared with 2018
Figure 79. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 80. Baxter International Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 81. C. R. Bard Total Revenue (US$ Million): 2019 Compared with 2018
Figure 82. The Medicines Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 83. Anika Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 84. Advanced Medical Solutions Total Revenue (US$ Million): 2019 Compared with 2018
Figure 85. Integra LifeSciences Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 86. B Braun Melsungen AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 87. Gelita Medical GmbH Total Revenue (US$ Million): 2019 Compared with 2018
Figure 88. Equimedical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. Vascular Solutions Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Marine Polymer Technologies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Z-Medica, LLC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. CryoLife Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. BioCer Entwicklungs-GmbH. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Biom'Up SAS Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Global Hemostats Revenue Forecast by Regions (2021-2026) (US$ Million)
Figure 96. Global Hemostats Revenue Market Share Forecast by Regions ((2021-2026))
Figure 97. Global Hemostats Production Forecast by Regions (2021-2026) (K Pcs)
Figure 98. North America Hemostats Production Forecast (2021-2026) (K Pcs)
Figure 99. North America Hemostats Revenue Forecast (2021-2026) (US$ Million)
Figure 100. Europe Hemostats Production Forecast (2021-2026) (K Pcs)
Figure 101. Europe Hemostats Revenue Forecast (2021-2026) (US$ Million)
Figure 102. China Hemostats Production Forecast (2021-2026) (K Pcs)
Figure 103. China Hemostats Revenue Forecast (2021-2026) (US$ Million)
Figure 104. Japan Hemostats Production Forecast (2021-2026) (K Pcs)
Figure 105. Japan Hemostats Revenue Forecast (2021-2026) (US$ Million)
Figure 106. Global Hemostats Consumption Market Share Forecast by Region (2021-2026)
Figure 107. Hemostats Value Chain
Figure 108. Channels of Distribution
Figure 109. Distributors Profiles
Figure 110. Porter's Five Forces Analysis
Figure 111. Bottom-up and Top-down Approaches for This Report
Figure 112. Data Triangulation
Figure 113. Key Executives Interviewed
Figure 1. Hemostats Product Picture
Figure 2. Global Hemostats Production Market Share by Type in 2020 & 2026
Figure 3. Thrombin-Based Hemostats Product Picture
Figure 4. Oxidized Regenerated Cellulose Based Hemostats Product Picture
Figure 5. Combination Hemostats Product Picture
Figure 6. Gelatin Based Hemostats Product Picture
Figure 7. Collagen Based Hemostats Product Picture
Figure 8. Global Hemostats Consumption Market Share by Application in 2020 & 2026
Figure 9. Prehospital Treatment
Figure 10. Hospital Treatment
Figure 11. Hemostats Report Years Considered
Figure 12. Global Hemostats Revenue 2015-2026 (Million US$)
Figure 13. Global Hemostats Production Capacity 2015-2026 (K Pcs)
Figure 14. Global Hemostats Production 2015-2026 (K Pcs)
Figure 15. Global Hemostats Market Share Scenario by Region in Percentage: 2020 Versus 2026
Figure 16. Hemostats Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 17. Global Hemostats Production Share by Manufacturers in 2015
Figure 18. The Top 10 and Top 5 Players Market Share by Hemostats Revenue in 2019
Figure 19. Global Hemostats Production Market Share by Region (2015-2020)
Figure 20. Hemostats Production Growth Rate in North America (2015-2020) (K Pcs)
Figure 21. Hemostats Revenue Growth Rate in North America (2015-2020) (US$ Million)
Figure 22. Hemostats Production Growth Rate in Europe (2015-2020) (K Pcs)
Figure 23. Hemostats Revenue Growth Rate in Europe (2015-2020) (US$ Million)
Figure 24. Hemostats Production Growth Rate in China (2015-2020) (K Pcs)
Figure 25. Hemostats Revenue Growth Rate in China (2015-2020) (US$ Million)
Figure 26. Hemostats Production Growth Rate in Japan (2015-2020) (K Pcs)
Figure 27. Hemostats Revenue Growth Rate in Japan (2015-2020) (US$ Million)
Figure 28. Global Hemostats Consumption Market Share by Regions 2015-2020
Figure 29. North America Hemostats Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 30. North America Hemostats Consumption Market Share by Application in 2019
Figure 31. North America Hemostats Consumption Market Share by Countries in 2019
Figure 32. U.S. Hemostats Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 33. Canada Hemostats Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 34. Europe Hemostats Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 35. Europe Hemostats Consumption Market Share by Application in 2019
Figure 36. Europe Hemostats Consumption Market Share by Countries in 2019
Figure 37. Germany Hemostats Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 38. France Hemostats Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 39. U.K. Hemostats Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 40. Italy Hemostats Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 41. Russia Hemostats Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 42. Asia Pacific Hemostats Consumption and Growth Rate (K Pcs)
Figure 43. Asia Pacific Hemostats Consumption Market Share by Application in 2019
Figure 44. Asia Pacific Hemostats Consumption Market Share by Regions in 2019
Figure 45. China Hemostats Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 46. Japan Hemostats Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 47. South Korea Hemostats Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 48. India Hemostats Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 49. Australia Hemostats Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 50. Taiwan Hemostats Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 51. Indonesia Hemostats Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 52. Thailand Hemostats Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 53. Malaysia Hemostats Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 54. Philippines Hemostats Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 55. Vietnam Hemostats Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 56. Latin America Hemostats Consumption and Growth Rate (K Pcs)
Figure 57. Latin America Hemostats Consumption Market Share by Application in 2019
Figure 58. Latin America Hemostats Consumption Market Share by Countries in 2019
Figure 59. Mexico Hemostats Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 60. Brazil Hemostats Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 61. Argentina Hemostats Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 62. Middle East and Africa Hemostats Consumption and Growth Rate (K Pcs)
Figure 63. Middle East and Africa Hemostats Consumption Market Share by Application in 2019
Figure 64. Middle East and Africa Hemostats Consumption Market Share by Countries in 2019
Figure 65. Turkey Hemostats Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 66. Saudi Arabia Hemostats Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 67. UAE Hemostats Consumption and Growth Rate (2015-2020) (K Pcs)
Figure 68. Global Hemostats Production Market Share by Type (2015-2020)
Figure 69. Global Hemostats Production Market Share by Type in 2019
Figure 70. Global Hemostats Revenue Market Share by Type (2015-2020)
Figure 71. Global Hemostats Revenue Market Share by Type in 2019
Figure 72. Global Hemostats Production Market Share Forecast by Type (2021-2026)
Figure 73. Global Hemostats Revenue Market Share Forecast by Type (2021-2026)
Figure 74. Global Hemostats Market Share by Price Range (2015-2020)
Figure 75. Global Hemostats Consumption Market Share by Application (2015-2020)
Figure 76. Global Hemostats Value (Consumption) Market Share by Application (2015-2020)
Figure 77. Global Hemostats Consumption Market Share Forecast by Application (2021-2026)
Figure 78. Ethicon Total Revenue (US$ Million): 2019 Compared with 2018
Figure 79. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 80. Baxter International Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 81. C. R. Bard Total Revenue (US$ Million): 2019 Compared with 2018
Figure 82. The Medicines Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 83. Anika Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 84. Advanced Medical Solutions Total Revenue (US$ Million): 2019 Compared with 2018
Figure 85. Integra LifeSciences Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 86. B Braun Melsungen AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 87. Gelita Medical GmbH Total Revenue (US$ Million): 2019 Compared with 2018
Figure 88. Equimedical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. Vascular Solutions Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Marine Polymer Technologies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Z-Medica, LLC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. CryoLife Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. BioCer Entwicklungs-GmbH. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Biom'Up SAS Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Global Hemostats Revenue Forecast by Regions (2021-2026) (US$ Million)
Figure 96. Global Hemostats Revenue Market Share Forecast by Regions ((2021-2026))
Figure 97. Global Hemostats Production Forecast by Regions (2021-2026) (K Pcs)
Figure 98. North America Hemostats Production Forecast (2021-2026) (K Pcs)
Figure 99. North America Hemostats Revenue Forecast (2021-2026) (US$ Million)
Figure 100. Europe Hemostats Production Forecast (2021-2026) (K Pcs)
Figure 101. Europe Hemostats Revenue Forecast (2021-2026) (US$ Million)
Figure 102. China Hemostats Production Forecast (2021-2026) (K Pcs)
Figure 103. China Hemostats Revenue Forecast (2021-2026) (US$ Million)
Figure 104. Japan Hemostats Production Forecast (2021-2026) (K Pcs)
Figure 105. Japan Hemostats Revenue Forecast (2021-2026) (US$ Million)
Figure 106. Global Hemostats Consumption Market Share Forecast by Region (2021-2026)
Figure 107. Hemostats Value Chain
Figure 108. Channels of Distribution
Figure 109. Distributors Profiles
Figure 110. Porter's Five Forces Analysis
Figure 111. Bottom-up and Top-down Approaches for This Report
Figure 112. Data Triangulation
Figure 113. Key Executives Interviewed
